Agios Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
166,769.00
342,065.00
317,002.00
541,314.00
423,936.00
585,302
Total Accounts Receivable
476.00
8,826.00
11,599.00
8,314.00
3,839.00
10,442
Other Current Assets
2,502.00
8,655.00
8,728.00
10,264.00
17,486.00
17,167
Total Current Assets
169,747.00
359,546.00
337,329.00
559,892.00
445,261.00
613,780
Net Property, Plant & Equipment
3,758.00
6,386.00
23,220.00
25,337.00
24,431.00
24,320
Total Investments and Advances
27,696.00
125,382.00
58,905.00
32,250.00
143,814.00
220,119
Other Assets
4.00
590.00
611.00
1,615.00
891.00
238
Total Assets
201,205.00
491,904.00
420,065.00
619,094.00
614,397.00
858,457
Accounts Payable
3,678.00
11,067.00
14,748.00
17,106.00
22,767.00
Income Tax Payable
1,462.00
-
-
-
-
Other Current Liabilities
31,790.00
50,022.00
38,140.00
71,327.00
72,174.00
Total Current Liabilities
36,930.00
61,089.00
52,888.00
88,433.00
94,941.00
Other Liabilities
32,793.00
6,449.00
22,059.00
172,070.00
143,953.00
Total Liabilities
69,723.00
67,538.00
74,947.00
260,503.00
238,894.00
Common Equity (Total)
131,482.00
424,366.00
345,118.00
358,591.00
375,503.00
Total Shareholders' Equity
131,482.00
424,366.00
345,118.00
358,591.00
375,503.00
Total Equity
131,482.00
424,366.00
345,118.00
358,591.00
375,503.00
Liabilities & Shareholders' Equity
201,205.00
491,904.00
420,065.00
619,094.00
614,397.00
About Agios Pharmaceuticals
View Profile
